Prolight Diagnostics AB (publ) (NGM:PRLD)
19.40
-1.40 (-6.73%)
At close: Sep 23, 2026
Prolight Diagnostics AB Revenue
Prolight Diagnostics AB had revenue of 2.84M SEK in the quarter ending June 30, 2026, a decrease of -79.63%. This brings the company's revenue in the last twelve months to 30.63M, down -31.10% year-over-year. In the year 2025, Prolight Diagnostics AB had annual revenue of 42.20M with 16.16% growth.
Revenue (ttm)
30.63M
Revenue Growth
-31.10%
P/S Ratio
7.63
Revenue / Employee
1.39M
Employees
22
Market Cap
233.67M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 42.20M | 5.87M | 16.16% |
| Dec 31, 2024 | 36.33M | 12.11M | 50.02% |
| Dec 31, 2023 | 24.22M | 15.18M | 167.90% |
| Dec 31, 2022 | 9.04M | 8.93M | 8,305.00% |
| Dec 31, 2021 | 107.54K | -717.02K | -86.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Invoicery Group AB | 1.94B |
| Tura Group AB | 1.06B |
| Nodebis Applications AB | 104.19M |
| Argo Defence Group Ab (Publ) | 94.46M |
| Preservium Property AB | 76.86M |
| Fable Media Group AB | 67.41M |
| Medclair AB | 53.14M |
| Enrad AB | 42.74M |
Prolight Diagnostics AB News
- 4 weeks ago - Prolight Diagnostics AB Quarterly report: Q2 2026 - Filings
- 4 months ago - Prolight Diagnostics AB Quarterly report: Q1 2026 - Filings
- 7 months ago - Prolight Diagnostics AB Quarterly report: Q4 2025 - Filings
- 7 months ago - Prolight Diagnostics AB Annual report: Q4 2025 - Filings
- 10 months ago - Prolight Diagnostics AB Quarterly report: Q3 2025 - Filings